Acne Vulgaris Market Seen Rising to $11.46B by 2030

The global acne vulgaris market is projected to grow from $8.44 billion in 2025 to $8.99 billion in 2026, with North America holding the largest share and Asia-Pacific expected to grow fastest. The Business Research Company says demand for skincare products, digital health tools and specialized therapies is pushing the market toward $11.46 billion by 2030.

Why it matters: - Acne vulgaris remains a common chronic skin condition, and rising treatment demand is driving spending across prescription drugs, skincare, teledermatology and e-commerce. - The market's growth signals broader consumer interest in dermatology care and a larger opportunity for both pharmaceutical and skincare companies. - The Business Research Company projects the market will reach $11.46 billion by 2030, up from $8.99 billion in 2026.

What happened: - The Business Research Company released a 2026 acne vulgaris market report covering market size, growth drivers, regional patterns and leading competitors. - The market is projected to rise from $8.44 billion in 2025 to $8.99 billion in 2026, a 6.5% CAGR. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Acne vulgaris is an inflammatory disorder of the skin's pilosebaceous units. - The condition can appear as comedones, papules, pustules, nodules and cysts. - Acne often develops because of excess sebum production, follicular hyperkeratinization, bacterial overgrowth, especially Cutibacterium acnes, and inflammation. - Acne commonly affects the face, chest and back. - Severity ranges from mild to severe, and the condition can lead to scarring. - Growth in 2026 is linked to higher acne incidence among adolescents, greater awareness of dermatological treatment, expansion of hospitals and clinics, wider access to prescription acne drugs and stronger focus on cosmetic and skincare routines. - By 2030, growth is expected to come from specialized acne therapies, more use of teledermatology and digital health platforms, stronger demand for anti-inflammatory and retinoid products, more personalized skincare and growth in online pharmacies and e-commerce. - Emerging trends include combination topical treatments, hormonal therapies, laser and light-based treatments, oral retinoids and antibiotics, and herbal, natural and alternative therapies. - Skincare products are a major growth driver because consumers are seeking products for cleansing, moisturizing, protection and acne management. - Active ingredients used in acne-focused skincare include salicylic acid, benzoyl peroxide and retinoids. - These ingredients help exfoliate skin, reduce inflammation and support clearer skin. - The Cosmetic, Toiletry and Perfumery Association said the European cosmetics market reached €96 billion in 2023, up from €88 billion in 2022. - The market report adds new 2026 features including market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report points to a market moving beyond basic acne creams toward a broader care ecosystem that includes digital consultations, combination therapies and personalized treatment plans. - Strong skincare spending suggests acne care is becoming tied more closely to consumer wellness and cosmetic routines, not just clinical treatment. - Regional growth patterns indicate mature demand in North America and more room for expansion in Asia-Pacific and other emerging markets.

What's next: - The market is expected to keep expanding as new therapies and digital care models reach more patients. - Online pharmacies and e-commerce channels are likely to become more important as consumers look for easier access to acne products. - The report says future growth will also be shaped by greater adoption of natural, herbal and alternative treatment options.

The bottom line: - Acne vulgaris is moving from a steady dermatology category into a faster-growing global market shaped by consumer skincare habits, digital care and product innovation.